The effect of thyroid hormones on concentrations of Iipoprotein(a) [Lp(a)] was analyzed in 60 patients with active thyroid dysfunction (hyperthyroidism 30 cases, hypothyroidism 32 cases, and 2 cases with opposite changes) and after normalization of the thyroid state. Treatment of hyperthyroidism increased the mean Lp(a) concentrations by 60% (from 73 to 102 mg/L, P <0.002); at the same time, low-density lipoprotein cholesterol (LDL-C) increased by 53% (from 2.6 to 3.7 mmol/L, P <0.0001) and apolipoprotein B (apo B) by 35% (from 0.91 to 1.17 gIL, P <0.0005). In hypothyroidism,the opposite changes were observed: mean I..p(a)decreased from 136 to 114 mg/L (10%, P <0.02), LDL-C from 4.6 to 3.9 mmol/L (13%, P <0.01), and apo B from 1.51 to 1.20 g/L (14%, P <0.01). Although the changes in Lp(a) concentrations did correlate with changes of LDL-C during treatment of hyperthyroidism (r = 0.43, P <0.05), and with changes in apo B during thyroxine-substitutiontherapy for hypothyroidism (r = 0.46, P <0.05), we observed no associations between Lp(a) and LDL-C or apo B in the euthyroid state. These data cannot rule out the possibility that the thyroid hormone-induced increase in LDL-C receptor activity was responsiblefor the decreased concentrations of I..p(a) in hyperthyroidism. Given that LDL-C is -30% of the Lp(a) molecule but the changes in Lp(a) concentrations are comparable with those in LDL-C (60% vs 53%), and given that Lp(a) is metabolized by an LDL-C-receptor-independent pathway, the present data suggest a direct effect of thyroid hormones on Lp(a) syntheIndexIng However, the data available so far favor an LDL-C-receptor-independent pathway (9, 10). In the present study, we assessed the changes in Lp(a) concentrations during active thyroid dysfunction and in the euthyroid state. 
lipoprotein receptor
Thyroid disorders are known to influence lipoprotein metabolism (1) (2) (3) (4) (5) . The However, the data available so far favor an LDL-C-receptor-independent pathway (9, 10). In the present study, we assessed the changes in Lp(a) concentrations during active thyroid dysfunction and in the euthyroid state. 
PatIents and Methods

Patients
Resufts
The changes in thyroid and lipid markers are summarized in Table 1 The mean increase in Lp(a) was
60% (P <0.002 vs initial values).
Opposite changes were observed during T4 treatment of hypothyroidism: a marked increase in FF4 and T3, concomitant with a decrease in total cholesterol, LDL-C, and ape B. Again, the change in Lp(a) concentrations was significant, although this was only a decrease of 10% (P <0.02 vs initial values). In contrast to the situation in hyperthyroidism, the Lp(a) response to treatment of hypothyroidism displayed an extensive variety: Some patients showed a marked decrease (e.g., see Figure 1 ), whereas in other cases almost no changes were observed, and in a few cases Lp(a) concentrations increased.
The changes of ape B and LDL-C concentrations parallel those of Lp(a) (Figure 2) . No significant correlations were obtained between Lp(a) and apo B or LDL-C concentrations in euthyroid subjects. However, we observed a significant association between changes in concentrations of Lp(a) and of LDL-C in the hyperthyroid group (r = 0.43, P <0.05) and between changes of Lp(a) and of ape B in the hypothyroid group (r = 0.46, P <0.05). Again, the changes during treatment of hyperthyroidism were more pronounced than those seen during treatment with T4 substitution in hypothyroidism (Table2).
In two patients we were able to monitor lipid parameters over a long period during several changes in thyroid function (Figure 1) . One, a 76-year-old man with hyperthyroidism (supposedly Graves disease), was treated by radiotherapy with adjuvant therapy with methimazole.
Consequently, he developed hypothyroidism; the methimazole was stopped, and he became hyperthyroid again, which led to the reinstitution of the methiinazole therapy. Figure 1 (left) clearly indicates the opposite changes during the course of therapy in this patient. Figure 1 (right) depicts FT4 and Lp(a) concentrations in a 27-year-old woman with postpartum thyroiditis.
During her pregnancy, she had consulted with clinical symptoms of hyperthyroidism, but thyroid-function tests indicated she was euthyroid. The pregnancy had to be terminated early by caesarean section due to the development of high liver-enzyme/low platelet syndrome, and the patient delivered a healthy boy. Six months later, the woman developed hypothyroidism (initial data shown in Figure 1 ). High concentrations of antibodies to thyroid peroxidase were measured and substitution therapy with low-dose T4 was initiated.
Subsequently, the patient developed
hyperthyroidism, and therapy with propylthiouracil was started. Not only the anti-thyroid peroxidase antibodies, but also the TSH-receptor antibodies were slightly increased at this time. One year after delivery, the patient returned to an euthyroid state. Again, the course of Lp(a) was opposite that of FT4 during the whole course of therapy.
Discussion
Thyroid hormones influence not only total cholesterol, LDL-C, and ape B concentrations (3), they also clearly show an effect on Lp(a) concentrations (7, and the present study). Our own data (136 mgfL in the hypothyroid state) were even lower. Because the patient group studied by Klausen et al. was small (13 patients vs 30 in the present study), and the hormonal effect on Lp(a) is only small (mean decrease of 10% in the present study), conceivably the former authors were unable to show the effect we found. A further problem is posed by the great genetically determined variability in Lp(a) concentrations within the normal population (13, 14) . The behavior of Lp(a) as an acute-phase protein is another reason
why it may be difficult to demonstrate the effect of thyroid hormones on Lp(a) during T4 substitution therapy.
In contrast to the discrepant results for Lp(a), the changes in total cholesterol, LDL-C, and ape B are consistent in all three follow-up studies (6, 7, and present data) and confirm earlier findings (3, 5, 15): Hyperthyroidism leads to decreased total cholesterol, LDL-C, and ape B, whereas in hypothyroidism the opposite changes are observed. However, the changes were more pronounced during treatment of hyperthyroidism than of hypothyroidism (Table 1 ). These data suggest that the effect of thyroid hormones is directly in the realm of protein synthesis. The T4-induced increase in concentrations of the mRNA for LDL-C receptors leads to an increase in LDL-receptor number and activity (2,4) and thus to a decrease in LDL-C and total cholesterol. Therefore, the increase in LDL-C and total cholesterol during hypothyroidism is caused by a decreased clearance rather than increased production or secretion of LDL-C.
Another mechanism leading to decreases in LDL-C and possibly also Lp(a) is the synthesis of ape B. In the animal model, an effect of thyroid hormones on processing of ape B mRNA has been demonstrated. Whereas thyroid hormones apparently have no effect on total concentrations of ape B mRNA, thyroid hormones modulate the editing of ape B mRNA, leading to a decrease in the abundance of ape B100 mRNA and an increase in ape B48 mRNA (16). Therefore, we postulate that thyroid hormones not only increase the clearance of LDL-C by increasing the activity of the LDL receptor, but suppress LDL-C synthesis through modulating the processing of ape B mRNA.
Little is known about how the concentration of Lp(a) is influenced by thyroid hormones. Given that Lp(a) is composed of ape(a) linked by disulfide bonds to ape B in the LDL-C particle, one could postulate that a decrease in synthesis of ape B100 would lead to a decrease in Lp(a) concentrations.
However 
